Recent market volatility interrupted what might have been a sharp rally in Crocs (CROX) stock after the leading footwear company posted strong Q2 results last Thursday.
Crocs (NASDAQ: CROX ) stock is moving higher following an insider buy. The buy came just one day after the foam clogs company reported its second-quarter earnings.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Regardless of market fluctuations, it's always a good time to invest in quality companies. Intuitive Surgical has a simple but effective business model that is driving impressive growth.
Crocs is growing, and it's trading for a good value, especially if the Hey Dude brand picks up again.
Crocs (NASDAQ: CROX ) stock is trading about 2% lower after the footwear company reported its second-quarter earnings. Crocs' revenue grew by 3.6% to $1.11 billion, beating the analyst estimate for $1.1 billion.
Crocs' (CROX) second-quarter 2024 results benefit from its brand strength and higher revenues across regions.
Crocs (CROX) delivered record revenue and earnings with its second-quarter results, but an underwhelming profit projection put a damper on the footwear company's momentum.
The casual-footwear maker's strong second-quarter earnings were overshadowed by a light third-quarter outlook. Investors shouldn't walk.
The casual-footwear firm walked all over second-quarter earnings and revenue estimates, and raised guidance. But there are still concerns over HeyDude.
Crocs, Inc. (NASDAQ:CROX) posted an earnings beat for the second quarter but shares of the footwear brand tumbled more than 7% on disappointing guidance. For 3Q, revenue is expected to be down 1.5% to up 0.5% from the year-ago quarter, with the Crocs brand seen growing 3% to 5% and HEYDUDE down 16% to 14%.
Crocs (CROX) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.59 per share. This compares to earnings of $3.59 per share a year ago.